Codexis, Inc. (CDXS) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
Codexis (CDXS) Q1 2026: Gross Margin Expands 16 Points as Ecosynthesis Platform Gains Traction
May 08, 2026
-
Codexis (CDXS) Q4 2025: EcoSynthesis Drives $38.9M Revenue Surge as RNA Platform Gains Traction
March 12, 2026
-
Codexis (CDXS) Q3 2025: Eco Platform Contracts Jump to 11, Accelerating Oligonucleotide Manufacturing Pivot
November 07, 2025
-
Codexis (CDXS) Q2 2025: Gross Margin Jumps 27 Points as Ecosynthesis Demand Outpaces Capacity
August 13, 2025
-
Codexis (CDXS) Q1 2025: Product Gross Margin Climbs to 55% as Ecosynthesis Platform Gains Commercial Traction
July 03, 2025